ISEE

IVERIC bio Stock Price

17.625
1.26 (7.67%)
Upgrade to Real-Time
Regular Market
17.625

Low
4.9601

52 Week Range

High
18.01

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
IVERIC bio Inc ISEE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
1.26 7.67% 17.625 13:31:11
Open Price Low Price High Price Close Price Prev Close
16.72 16.12 18.01 16.37
Bid Price Ask Price Spread News
17.62 17.63 0.01 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
20,503 3,270,283 $ 17.44 $ 57,047,386 - 4.9601 - 18.01
Last Trade Time Type Quantity Stock Price Currency
13:31:23 100 $ 17.625 USD

Period:

Draw Mode:

IVERIC bio Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.84B 104.01M 103.50M $ - $ - -1.14 -13.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 250.00k 0.60%

more financials information »

IVERIC bio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ISEE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week16.0018.0115.8516.232,161,1971.6310.16%
1 Month10.4918.018.3714.1213,170,5297.1468.02%
3 Months8.3018.017.5512.885,796,9649.33112.35%
6 Months6.0118.015.6011.983,088,45211.62193.26%
1 Year5.4318.014.960110.861,916,15612.20224.59%
3 Years1.3318.010.90598.551,224,40216.301,225.19%
5 Years1.3318.010.90598.551,224,40216.301,225.19%

IVERIC bio Description

IVERIC bio Inc is a biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The company is developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases, or IRDs.


Your Recent History
NASDAQ
ISEE
IVERIC bio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.